NCT00803803View on ClinicalTrials.gov

Dose, Effects and Characteristics of Pilocarpine

PHASE4CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

August 31, 1978

Primary Completion Date

August 31, 1979

Study Completion Date

December 31, 1979

Conditions
Open-angle Glaucoma
Interventions
DRUG

Pilocarpine Concentration

Varying concentration 0.5 to 8%

DRUG

Pilocarpine Frequency

1 to 4 times daily

Trial Locations (1)

19107

Wills Eye Glaucoma Service, Philadelphia

All Listed Sponsors
lead

Wills Eye

OTHER

NCT00803803 - Dose, Effects and Characteristics of Pilocarpine | Biotech Hunter | Biotech Hunter